Form 4 for JSPR Jasper Therapeutics, Inc.
Accepted 2022-10-13 00:00:00 ET · period of report 2022-10-12 · accession 0001213900-22-063943 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-13 | 2022-10-12 | JSPR | Shizuru Judith Anne | Dir | A - Grant | $0.00 | +29.5K | 1.16M | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2022-10-12 | A | A | 29,500 | $0.00 | 1,159,012 | D | — | — | (F1) The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. |